Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jan;18(1):20-5.
doi: 10.1007/BF00449685.

3(3) factorial design-based optimization of the formulation of nitrofurantoin microcapsules

Affiliations

3(3) factorial design-based optimization of the formulation of nitrofurantoin microcapsules

H Y Karasulu et al. Pharm World Sci. 1996 Jan.

Abstract

A microcapsule form of nitrofurantoin was prepared by a simple coacervation method with carboxymethylcellulose and aluminium sulfate. 3(3) factorial design was performed for three independent variables, namely, the particle size of the drug, the size of the microcapsules and the pH of the dissolution medium. The dissolution tests with the formulated microcapsules were carried out according to the United States Pharmacopeia XXII rotating basket method at pH 1.2, 5, and 7.5, which represent the pH of gastrointestinal fluids. Release data were examined kinetically and the ideal kinetic models were estimated and t(63.2) values obtained from RRSBW distribution were used in the factorial design experiment. The influence of the independent variables on the dissolution of nitrofurantoin microcapsules could be expressed as the pH of the dissolution medium > particle size of the microcapsule > particle size of nitrofurantoin. The other aim of this study was to evaluate microcapsule formulation in terms of the United States Pharmacopeia criteria with a minimum of experiments. Our findings suggest that dosage forms which comply with the pharmacopoeia criteria for dissolution can be prepared and selected by factorial design.

PubMed Disclaimer

References

    1. J Pharm Sci. 1972 Sep;61(9):1430-5 - PubMed
    1. J Pharm Sci. 1973 May;62(5):795-8 - PubMed
    1. Arzneimittelforschung. 1974 Jan;24(1):39-43 - PubMed
    1. J Pharm Sci. 1967 Jul;56(7):882-5 - PubMed
    1. Pharm Res. 1993 Apr;10(4):621-6 - PubMed

MeSH terms